PT-141
10mg of active ingredient included in vial.
PT-141, scientifically known as Bremelanotide, operates by targeting and activating specific
receptors in the brain called melanocortin receptors, primarily MC4R (Melanocortin 4
Receptor) and MC3R (Melanocortin 3 Receptor). These receptors are part of the
melanocortin system, which plays a crucial role in regulating a wide range of physiological
functions, including sexual desire and arousal. When PT-141 binds to these receptors, it
triggers a cascade of neural signals that result in increased sexual desire and improved
sexual response.
This mechanism is believed to address sexual dysfunction by enhancing the brain's
signaling pathways related to sexual arousal. Unlike some other treatments for sexual
dysfunction, PT-141 acts centrally in the brain, making it a potentially eective option for
individuals with various forms of sexual dysfunction, including female sexual arousal
disorder (FSAD) and erectile dysfunction (ED). Research into the science behind PT-141
continues to advance, shedding light on its precise mechanisms and potential applications
in sexual health.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
